Pictet - Biotech - HP CHF/ LU0843168732 /
NAV26/08/2024 | Chg.+7.1600 | Type de rendement | Focus sur l'investissement | Société de fonds |
---|---|---|---|---|
715.6200CHF | +1.01% | reinvestment | Equity Worldwide | Pictet AM (EU) ▶ |
Performance mensuelle
janv. | févr. | mars | avr. | mai | juin | juil. | août | sept. | oct. | nov. | déc. | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2012 | - | - | - | - | - | - | - | - | - | - | - | -1.70 | - |
2013 | 7.42 | 0.45 | 7.42 | 6.54 | 2.79 | -4.28 | 12.02 | -0.08 | 8.56 | -5.20 | 7.32 | 2.00 | +53.23% |
2014 | 9.16 | 7.10 | -10.17 | -7.06 | 1.51 | 7.76 | -2.34 | 8.02 | -1.75 | 8.25 | 2.54 | -0.06 | +22.77% |
2015 | 6.66 | 5.29 | 1.54 | -4.98 | 11.06 | 1.77 | 3.05 | -9.56 | -10.38 | 4.89 | 3.08 | -0.15 | +10.43% |
2016 | -22.33 | -6.09 | 4.03 | 3.08 | 4.11 | -8.04 | 12.09 | -4.70 | 1.66 | -10.94 | 7.39 | -3.76 | -25.15% |
2017 | 6.49 | 7.08 | -1.09 | 1.75 | -4.49 | 9.12 | 2.49 | 4.67 | -0.28 | -6.93 | -0.32 | 2.06 | +21.15% |
2018 | 6.51 | -5.40 | -2.50 | -3.80 | 3.92 | 1.08 | 3.50 | 3.35 | -1.73 | -13.90 | 2.10 | -10.15 | -17.56% |
2019 | 14.40 | 4.07 | -1.51 | -3.91 | -4.27 | 8.20 | 0.08 | -5.79 | -5.93 | 7.75 | 13.18 | 0.10 | +26.36% |
2020 | -4.42 | -2.50 | -4.50 | 17.20 | 5.21 | 1.84 | -1.20 | 0.16 | 5.75 | -3.48 | 7.00 | 3.84 | +25.45% |
2021 | 3.68 | -3.15 | -4.15 | 1.64 | -4.72 | 4.14 | -1.86 | 4.50 | -3.32 | -2.24 | -6.26 | 2.25 | -9.82% |
2022 | -18.68 | -2.50 | 3.39 | -10.02 | -4.14 | 4.54 | 5.93 | 4.40 | -2.44 | 1.83 | 4.14 | -3.28 | -18.20% |
2023 | 2.28 | -4.59 | -3.01 | 4.98 | -0.39 | 0.44 | 0.19 | -1.30 | -5.14 | -11.76 | 11.90 | 18.05 | +8.69% |
2024 | 1.27 | 5.28 | -3.75 | -8.19 | 1.84 | 6.40 | 5.66 | 1.39 | - | - | - | - | - |
Valeurs calculées
CAD | 6 Mois | 1 An | 3 Ans | 5 Ans | |
---|---|---|---|---|---|
Volatilité | 22.60% | 23.15% | 23.86% | 25.74% | 25.35% |
Ratio de Sharpe | 0.50 | 0.27 | 0.76 | -0.29 | 0.05 |
Le meilleur mois | +18.05% | +6.40% | +18.05% | +18.05% | +18.05% |
Le plus défavorable mois | -8.19% | -8.19% | -11.76% | -18.68% | -18.68% |
Perte maximale | -15.82% | -15.82% | -17.14% | -42.01% | -47.40% |
Surperformance | +7.81% | - | +9.16% | -0.65% | -19.80% |
Toutes les cotations dans CHF
Tranches
Nom | Type de rendement | Prix de rachat | 1 An | 3 Ans | |
---|---|---|---|---|---|
Pictet - Biotech - I USD | reinvestment | 1,216.9100 | +28.37% | +2.42% | |
Pictet - Biotech - I EUR | reinvestment | 1,091.0900 | +24.32% | +7.87% | |
Pictet - Biotech - HI EUR | reinvestment | 657.7600 | +25.56% | -5.14% | |
Pictet - Biotech - I dy GBP | paying dividend | 923.3900 | +22.59% | +6.54% | |
Pictet-Biotech Z | reinvestment | 1,376.6500 | +29.66% | +5.53% | |
Pictet - Biotech - HZ CHF | reinvestment | 1,123.8300 | +23.82% | - | |
Pictet - Biotech - P dy USD | paying dividend | 1,007.4800 | +27.24% | -0.29% | |
Pictet - Biotech - HP EUR | reinvestment | 609.6700 | +24.45% | -7.66% | |
Pictet - Biotech - P EUR | reinvestment | 903.2100 | +23.22% | +5.01% | |
Pictet - Biotech - R USD | reinvestment | 862.0600 | +26.35% | -2.37% | |
Pictet - Biotech - R EUR | reinvestment | 772.4500 | +22.36% | +2.83% | |
Pictet - Biotech - HR EUR | reinvestment | 521.3800 | +23.58% | -9.58% | |
Pictet - Biotech - P dy GBP | paying dividend | 764.0200 | +21.50% | +3.72% | |
Pictet - Biotech - HP CHF | reinvestment | 715.6200 | +21.52% | -11.00% | |
Pictet - Biotech - HR AUS | reinvestment | 829.8100 | +23.55% | - | |
Pictet - Biotech - HR dm ZAR | paying dividend | 8,324.3496 | +28.62% | - | |
Pictet - Biotech - P USD | reinvestment | 1,007.8500 | +27.24% | -0.29% |
Performance
CAD | +9.36% | ||
---|---|---|---|
6 Mois | +4.76% | ||
1 An | +21.52% | ||
3 Ans | -11.00% | ||
5 Ans | +26.09% | ||
10 ans | +24.88% | ||
Depuis le début | +111.21% | ||
Année | |||
2023 | +8.69% | ||
2022 | -18.20% | ||
2021 | -9.82% | ||
2020 | +25.45% | ||
2019 | +26.36% | ||
2018 | -17.56% | ||
2017 | +21.15% | ||
2016 | -25.15% | ||
2015 | +10.43% |